Amy Rachfal, PhD
— Chief Clinical Science Officer, Clinical Development Strategy and Execution
Dr. Amy Rachfal, PhD, is Principal and Chief Scientific Officer of Stage Gate Partners, LLC, an independent clinical development consultancy she co-founded in 2014, and works with NGT as an independent consultant leading Clinical Development Strategy and Execution. A molecular biologist, she has over 20 years of experience in integrated clinical and clinical regulatory drug development strategy, spanning leadership roles in a regulatory and scientific communications agency (Scientific Director) and Pharma (Clinical Development, Medical Affairs, Scientific Communications), and as an independent consultant. Her experience covers a broad range of therapeutic areas, US and non US regulatory interactions (including FDA Advisory Committees), and collaboration with more than 60 Biotech, Pharma, Clinical Research Organizations and Pharma agencies.
Expertise Overview
- Strategic clinical development program and trial planning
- Integral member of cross-functional teams representing Clinical Development and Medical Affairs developing and implementing strategy and tactics for first intent and label expansion programs
- Clinical-Regulatory engagement strategy and execution, Scientific lead for multiple FDA Advisory Committee preparation teams, and primary clinical/scientific support in innumerable FDA meetings
- Indication evaluation and assessment, portfolio review, asset repositioning, due diligence
- Clinical guidance for translational plans
- Medical affairs and scientific communication strategy